Skip to main content

1 Result(s)

within Brice Korkmaz Remove this filter Medicine & Public Health Remove this filter

and

  1. Article

    Open Access

    Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial

    Brensocatib is an oral, selective, reversible inhibitor of dipeptidyl peptidase-1 (DPP-1), responsible for activating neutrophil serine proteases (NSPs) including neutrophil elastase (NE), proteinase 3 (PR3), ...

    David Cipolla, Jimin Zhang, Brice Korkmaz, James D. Chalmers… in Respiratory Research (2023)

    Download PDF (2859 KB) View Article